269 related articles for article (PubMed ID: 20147844)
1. Caspase inhibition modulates left ventricular remodeling following myocardial infarction through cellular and extracellular mechanisms.
Yarbrough WM; Mukherjee R; Stroud RE; Meyer EC; Escobar GP; Sample JA; Hendrick JW; Mingoia JT; Spinale FG
J Cardiovasc Pharmacol; 2010 Apr; 55(4):408-16. PubMed ID: 20147844
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic inhibition of intracellular caspases after myocardial infarction attenuates left ventricular remodeling: a potentially novel pathway.
Yarbrough WM; Mukherjee R; Escobar GP; Sample JA; McLean JE; Dowdy KB; Hendrick JW; Gibson WC; Hardin AE; Mingoia JT; White PC; Stiko A; Armstrong RC; Crawford FA; Spinale FG
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1892-9. PubMed ID: 14688702
[TBL] [Abstract][Full Text] [Related]
3. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
[TBL] [Abstract][Full Text] [Related]
4. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction.
Chandrashekhar Y; Sen S; Anway R; Shuros A; Anand I
J Am Coll Cardiol; 2004 Jan; 43(2):295-301. PubMed ID: 14736452
[TBL] [Abstract][Full Text] [Related]
5. Intracoronary delivery of recombinant TIMP-3 after myocardial infarction: effects on myocardial remodeling and function.
Barlow SC; Doviak H; Jacobs J; Freeburg LA; Perreault PE; Zellars KN; Moreau K; Villacreses CF; Smith S; Khakoo AY; Lee T; Spinale FG
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H690-H699. PubMed ID: 28754718
[TBL] [Abstract][Full Text] [Related]
6. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
7. Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.
Zheng XX; Li XY; Lyu YN; He YY; Wan WG; Zhu HL; Jiang XJ
Exp Physiol; 2016 Feb; 101(2):260-71. PubMed ID: 26556551
[TBL] [Abstract][Full Text] [Related]
8. Dihydroxyflavonol reduces post-infarction left ventricular remodeling by preventing myocyte apoptosis in the non-infarcted zone in goats.
Wang S; Fei K; Xu YW; Wang LX; Chen YQ
Chin Med J (Engl); 2009 Jan; 122(1):61-7. PubMed ID: 19187619
[TBL] [Abstract][Full Text] [Related]
9. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
10. Myocardial infarct expansion and matrix metalloproteinase inhibition.
Mukherjee R; Brinsa TA; Dowdy KB; Scott AA; Baskin JM; Deschamps AM; Lowry AS; Escobar GP; Lucas DG; Yarbrough WM; Zile MR; Spinale FG
Circulation; 2003 Feb; 107(4):618-25. PubMed ID: 12566376
[TBL] [Abstract][Full Text] [Related]
11. Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.
Blom AS; Pilla JJ; Gorman RC; Gorman JH; Mukherjee R; Spinale FG; Acker MA
Heart Fail Rev; 2005 Jun; 10(2):125-39. PubMed ID: 16258720
[TBL] [Abstract][Full Text] [Related]
12. Regional and temporal changes in left ventricular strain and stiffness in a porcine model of myocardial infarction.
Torres WM; Jacobs J; Doviak H; Barlow SC; Zile MR; Shazly T; Spinale FG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H958-H967. PubMed ID: 30004234
[TBL] [Abstract][Full Text] [Related]
13. Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction.
Blom AS; Mukherjee R; Pilla JJ; Lowry AS; Yarbrough WM; Mingoia JT; Hendrick JW; Stroud RE; McLean JE; Affuso J; Gorman RC; Gorman JH; Acker MA; Spinale FG
Circulation; 2005 Aug; 112(9):1274-83. PubMed ID: 16129812
[TBL] [Abstract][Full Text] [Related]
14. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
[TBL] [Abstract][Full Text] [Related]
15. Selective targeting of matrix metalloproteinase inhibition in post-infarction myocardial remodeling.
Apple KA; Yarbrough WM; Mukherjee R; Deschamps AM; Escobar PG; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Stroud RE; O'Neill TP; Spinale FG
J Cardiovasc Pharmacol; 2006 Feb; 47(2):228-35. PubMed ID: 16495760
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A
Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562
[TBL] [Abstract][Full Text] [Related]
17. Post-infarct morphine treatment mitigates left ventricular remodeling and dysfunction in a rat model of ischemia-reperfusion.
Rajani SF; Imani A; Faghihi M; Izad M; Kardar GA; Salehi Z
Eur J Pharmacol; 2019 Mar; 847():61-71. PubMed ID: 30684466
[TBL] [Abstract][Full Text] [Related]
18. Targeted regional injection of biocomposite microspheres alters post-myocardial infarction remodeling and matrix proteolytic pathways.
Dixon JA; Gorman RC; Stroud RE; Mukherjee R; Meyer EC; Baker NL; Morita M; Hamamoto H; Ryan LP; Gorman JH; Spinale FG
Circulation; 2011 Sep; 124(11 Suppl):S35-45. PubMed ID: 21911817
[TBL] [Abstract][Full Text] [Related]
19. MMP induction and inhibition in myocardial infarction.
Lindsey ML
Heart Fail Rev; 2004 Jan; 9(1):7-19. PubMed ID: 14739764
[TBL] [Abstract][Full Text] [Related]
20. P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs.
Vilahur G; Gutiérrez M; Casani L; Lambert C; Mendieta G; Ben-Aicha S; Capdevila A; Pons-Lladó G; Carreras F; Carlsson L; Hidalgo A; Badimon L
Cardiovasc Res; 2018 Dec; 114(14):1860-1870. PubMed ID: 30124783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
